Clicky

TabletWise.com
    Pharmacy Website
    Clinic Website
     

    Intelligence » Psoriasis » Last Week

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    Almirall steps into psoriasis market with Ilumetri approval

    Wednesday, September 19, 2018 -- The European Commission has approved Almirall’s Ilumetri for moderate-to-severe chronic plaque psoriasis.

    Mixed Results with Reduced-Dose Psoriasis Tx

    Monday, September 17, 2018 -- (MedPage Today) -- Null trial but most patients do well on lower dose of biological

    EADV Poster Rounds: Psoriasis Comorbidity in Kids; Long-Term PsA Control

    Wednesday, September 19, 2018 -- (MedPage Today) -- Selected poster presentations from the European dermatology meeting

    EADV Poster Rounds: Psoriasis and Cancer; Scratch Control; Scalp Psoriasis

    Thursday, September 20, 2018 -- (MedPage Today) -- Selected poster presentations from the European dermatology congress

    Methotrexate Effective in Subcutaneous Psoriasis

    Saturday, September 15, 2018 -- (MedPage Today) -- Over 40% of patients achieved PASI 75 response in 16-week trial

    New Treatment for Plaque Psoriasis Approved in Europe

    Tuesday, September 18, 2018 -- Almirall has received European Commission approval for its plaque psoriasis treatment tildrakizumab (Ilumetri).